Intertriginous erythema associated with enfortumab vedotin, a nectin-4-targeting antibody-drug conjugate, in a case with metastatic urothelial cancer: Immunohistochemical evidence for molecular-targeted eruption.
Intertriginous erythema associated with enfortumab vedotin, a nectin-4-targeting antibody-drug conjugate, in a case with metastatic urothelial cancer: Immunohistochemical evidence for molecular-targeted eruption.
复制标题
在转移性尿路上皮癌病例中，与 enfortumab vedotin（一种 nectin-4 靶向抗体药物缀合物）相关的间擦红斑：分子靶向发疹的免疫组织化学证据。
DOI：
10.1111/1346-8138.16567
复制
发表时间：
2022
期刊：
影响因子：
3.1
通讯作者：
Hasegawa M.
中科院分区：
文献类型：
--
作者：
Hasegawa T;Oyama N;Kasamatsu H;Chino T;Taga M;Hasegawa M.
